Protective immunity against HIV infection: has nature done the experiment for us?
about
Immunovirological parameters and cytokines in HIV infectionReduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmissionbeta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaquesMaternal Trypanosoma cruzi infection upregulates capacity of uninfected neonate cells To produce pro- and anti-inflammatory cytokines.Local control of repeated-dose rectal challenges in DNA/MVA-vaccinated macaques protected against a first series of simian immunodeficiency virus challenges.Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatmentDNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies.Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus.Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.Regulation of bovine leukemia virus tax and pol mRNA levels by interleukin-2 and -10.Role of natural killer cells in resistance against friend retrovirus-induced leukemiaIdentification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes.Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individualsInduction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees.Immunomodulatory effect of zidovudine (ZDV) on cytotoxic T lymphocytes previously exposed to ZDVCellular HIV-1 immune responses in natural infection and after genetic immunization.Increased sensitivity of HIV-1 antibody detection.Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero.Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection.Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response.Evidence that high-dosage zidovudine at time of retrovirus exposure reduces antiviral efficacyType 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.Leishmania and human immunodeficiency virus coinfection: the first 10 yearsLow maternal viral loads and reduced granulocyte-macrophage colony-stimulating factor levels characterize exposed, uninfected infants who develop protective human immunodeficiency virus type 1-specific responses.Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infectionVaccine strategies for infectious diseases.Guiding the vaginal microbicide trials with biomarkers of inflammation.Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 alleleClinical utilization of chemokines to combat cancer: the double-edged sword.Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individualsInduction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.Cure for HIV: New possibility on horizonType 1 and type 2 cytokine gene expression by viral gp135 surface protein-activated T lymphocytes in caprine arthritis-encephalitis lentivirus infection.Persistently HIV-1 seronegative Nairobi sex workers are susceptible to in vitro infectionTh1/Th2 cytokine responses following HIV-1 immunization in seronegative volunteers. The AIDS Vaccine Evaluation Group.Human Immunodeficiency Virus type 1 in seronegative infants born to HIV-1-infected mothers.Detecting seronegative-early HIV infections among adult versus student Kenyan blood donors, by using Stimmunology.The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protection.Recruiting HLA to fight HIV.
P2860
Q26829264-23F0E24B-ADD9-40EB-9A44-1B9CFE3E4B53Q28362322-0E887AA8-3BFA-4D7E-9AF0-D12CB54DB9DFQ33555112-09AC2982-76A0-4D28-AB71-84837360FBA1Q33600538-8E0B576B-904C-42B1-AB48-9E5425B0B222Q33602810-7008DD06-8029-4352-AF33-27C01CA7E053Q33782843-CDE48485-07BE-44C0-A2F7-2D2023FB0CA6Q33783841-3A0E628E-B581-44D1-87E8-4E8F29D0D3CDQ33806129-B9382F36-E312-4F75-82A5-9F3215B17949Q33808774-10F3FFA3-05C1-431D-9D5C-0671D360543AQ33820243-3ABD732A-66A5-4F5A-B2AA-44E9543A3CFDQ33838025-EE4DC061-1FFA-4ED8-A521-FC7480611423Q33839448-62FFD633-290F-4020-8839-C44D9B82ACF5Q34020111-7400686B-4666-4BC7-BBA2-DB20CE0DDE56Q34069214-5905FC33-9807-4CA6-8D3E-46B3CE98BC13Q34113323-5F971163-CF9B-480A-A27E-A5F5C645DD66Q34172130-938D4B9F-20BF-458F-8A86-A7593A28651AQ34445202-75DB3F4F-CCE2-49E5-9D5B-39BE0B16F28BQ34461381-079C0423-02AF-4D25-A81E-FC1A4AF8DDC0Q34620836-611F25CE-0E8E-4B49-8146-C2A2C51562E6Q34949513-38B735A9-E58E-48E1-B12C-D9FC7D7DA237Q35127088-6BCC427E-7B96-4FDF-9492-B4C72C87FC9AQ35372676-6355CFE5-E9D3-4528-9754-38BD1126C37BQ35374078-15AEDBB5-7AC7-42DF-9314-C383430CCBE8Q35783507-40D78908-30F6-42B1-8985-2B0C027D19F2Q35895554-28595430-8569-4DFA-B5DF-E4C0C9A44D62Q36181264-366B2AC5-395B-49D3-A2CF-F7B2D69594ABQ36371385-9100C2C3-B87E-469F-8702-C4D5F69D5132Q36380434-DCC57C20-E927-45A8-AAE7-31D2D7395056Q36488894-7F53DAEE-AD18-47CE-BF7F-3C7A00544762Q37050078-C4E6F0C2-0B85-4B7C-84B7-D0369291678DQ37374425-DF2A781B-21EF-49E0-AC93-8A79DF3E3454Q37387851-A5575101-8815-4C8A-9940-805C843DFB54Q38549079-F4C7F035-8321-45D3-B59F-CB88C8ECBD62Q39880701-63DCF86B-FD00-4E1F-AE45-DD35F8CACEEEQ40662796-7BB93F3A-44DB-46CD-9246-F5EC9B10FAD4Q40868381-49EB5409-1A4F-4AA8-AF9A-CC2EC4F951A0Q42415295-2141FFC1-0C9E-4F8B-B75A-F0F92D676768Q43527701-120FE03D-703B-4F9B-BCCF-CDCB15670422Q43690745-C0195D91-7BBF-4F1E-9C72-AF29D2E726CDQ44042125-635AF52D-D2F1-4EED-84C8-90B86BD15ADE
P2860
Protective immunity against HIV infection: has nature done the experiment for us?
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Protective immunity against HIV infection: has nature done the experiment for us?
@en
type
label
Protective immunity against HIV infection: has nature done the experiment for us?
@en
prefLabel
Protective immunity against HIV infection: has nature done the experiment for us?
@en
P1433
P1476
Protective immunity against HIV infection: has nature done the experiment for us?
@en
P2093
Shearer GM
P356
10.1016/0167-5699(96)80564-0
P577
1996-01-01T00:00:00Z